1. Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus.
- Author
-
Sokolova AS, Yarovaya OI, Baranova DV, Galochkina AV, Shtro AA, Kireeva MV, Borisevich SS, Gatilov YV, Zarubaev VV, and Salakhutdinov NF
- Subjects
- Animals, Antiviral Agents pharmacology, Cell Line, Dogs, Hemagglutinin Glycoproteins, Influenza Virus metabolism, Influenza A Virus, H1N1 Subtype metabolism, Madin Darby Canine Kidney Cells, Orthomyxoviridae Infections drug therapy, Alkanes pharmacology, Ammonium Compounds pharmacology, Camphanes pharmacology, Influenza A Virus, H1N1 Subtype drug effects, Quaternary Ammonium Compounds pharmacology, Salts pharmacology
- Abstract
A series of compounds containing a 1,7,7-trimethylbicyclo[2.2.1]heptane fragment were evaluated for their antiviral activity against influenza A virus strain A/Puerto Rico/8/34 (H1N1) in vitro. The most potent antiviral compound proved to be a quaternary ammonium salt based on (-)-borneol, 10a. In in vitro experiments, compound 10a inhibited influenza A viruses (H1, H1pdm09, and H3 subtypes), with an IC
50 value of 2.4-16.8 µM (depending on the virus), and demonstrated low toxicity (CC50 = 1311 µM). Mechanism-of-action studies for compound 10a revealed it to be most effective when added at the early stages of the viral life cycle. In direct haemolysis inhibition tests, compound 10a was shown to decrease the membrane-disrupting activity of influenza A virus strain A/Puerto Rico/8/34. According to molecular modelling results, the lead compound 10a can bind to different sites in the stem region of the viral hemagglutinin.- Published
- 2021
- Full Text
- View/download PDF